Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane L Negley

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Virological Methods|May 26, 2004
Virus inactivation by nucleic acid extraction reagentsJamie A Blow, David J Dohm, Diane L Negley, et al.
The Journal of Infectious Diseases|December 6, 2007
Genomic differences between guinea pig lethal and nonlethal Marburg virus variantsLoreen L Lofts, M Sofi Ibrahim, Diane L Negley, et al.
Vaccine|April 7, 2005
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infectionsDana L Swenson, Kelly L Warfield, Diane L Negley, et al.
Vaccine|August 17, 2004
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infectionKelly L Warfield, Dana L Swenson, Diane L Negley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infectionKelly L Warfield, Gene Olinger, Emily M Deal, et al.
Vaccine|July 11, 2006
Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in miceJohn S Lee, Jennifer L Groebner, Angela G Hadjipanayis, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Virological Methods|May 26, 2004
Virus inactivation by nucleic acid extraction reagentsJamie A Blow, David J Dohm, Diane L Negley, et al.
The Journal of Infectious Diseases|December 6, 2007
Genomic differences between guinea pig lethal and nonlethal Marburg virus variantsLoreen L Lofts, M Sofi Ibrahim, Diane L Negley, et al.
Vaccine|April 7, 2005
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infectionsDana L Swenson, Kelly L Warfield, Diane L Negley, et al.
Vaccine|August 17, 2004
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infectionKelly L Warfield, Dana L Swenson, Diane L Negley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infectionKelly L Warfield, Gene Olinger, Emily M Deal, et al.
Vaccine|July 11, 2006
Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in miceJohn S Lee, Jennifer L Groebner, Angela G Hadjipanayis, et al.
Pageof 1